These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25382611)

  • 1. Hypermethylation of the tumor suppressor gene PRDM1/Blimp-1 supports a pathogenetic role in EBV-positive Burkitt lymphoma.
    Zhang T; Ma J; Nie K; Yan J; Liu Y; Bacchi CE; Queiroga EM; Gualco G; Sample JT; Orazi A; Knowles DM; Tam W
    Blood Cancer J; 2014 Nov; 4(11):e261. PubMed ID: 25382611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesis.
    Ma J; Nie K; Redmond D; Liu Y; Elemento O; Knowles DM; Tam W
    Leukemia; 2016 Mar; 30(3):594-604. PubMed ID: 26530011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.
    De Leo A; Arena G; Stecca C; Raciti M; Mattia E
    Mol Cancer Res; 2011 Oct; 9(10):1346-55. PubMed ID: 21856773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell leukemia I oncogene expression depends on the presence of Epstein-Barr virus in the virus-carrying Burkitt lymphoma lines.
    Kiss C; Nishikawa J; Takada K; Trivedi P; Klein G; Szekely L
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4813-8. PubMed ID: 12672960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.
    Kelly GL; Milner AE; Baldwin GS; Bell AI; Rickinson AB
    Proc Natl Acad Sci U S A; 2006 Oct; 103(40):14935-40. PubMed ID: 17001014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features.
    Sureda-Gómez M; Iaccarino I; De Bolòs A; Meyer M; Balsas P; Richter J; Rodríguez ML; López C; Carreras-Caballé M; Glaser S; Nadeu F; Jares P; Clot G; Siciliano MC; Bellan C; Tornambè S; Boccacci R; Leoncini L; Campo E; Siebert R; Amador V; Klapper W
    Blood; 2024 Jul; 144(2):187-200. PubMed ID: 38620074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral driven epigenetic events alter the expression of cancer-related genes in Epstein-Barr-virus naturally infected Burkitt lymphoma cell lines.
    Hernandez-Vargas H; Gruffat H; Cros MP; Diederichs A; Sirand C; Vargas-Ayala RC; Jay A; Durand G; Le Calvez-Kelm F; Herceg Z; Manet E; Wild CP; Tommasino M; Accardi R
    Sci Rep; 2017 Jul; 7(1):5852. PubMed ID: 28724958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
    Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
    J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent methylation of p16INK4A/p14ARF promoters in tumorigenesis of Epstein-Barr virus transformed lymphoblastoid cell lines.
    Nagy E; Veress G; Szarka K; Csoma E; Beck Z
    Anticancer Res; 2005; 25(3B):2153-60. PubMed ID: 16158958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of the interferon regulatory factor 5 promoter in Epstein-Barr virus-associated gastric carcinoma.
    Dong SM; Lee HG; Cho SG; Kwon SH; Yoon H; Kwon HJ; Lee JH; Kim H; Park PG; Kim H; Hayward SD; Park JH; Lee JM
    J Microbiol; 2015 Jan; 53(1):70-6. PubMed ID: 25557482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine signatures of transformed B cells with distinct Epstein-Barr virus latencies as a potential diagnostic tool for B cell lymphoma.
    Miyauchi K; Urano E; Yoshiyama H; Komano J
    Cancer Sci; 2011 Jun; 102(6):1236-41. PubMed ID: 21392167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5' regulatory sequences of active miR-146a promoters are hypomethylated and associated with euchromatic histone modification marks in B lymphoid cells.
    Szenthe K; Koroknai A; Banati F; Bathori Z; Lozsa R; Burgyan J; Wolf H; Salamon D; Nagy K; Niller HH; Minarovits J
    Biochem Biophys Res Commun; 2013 Apr; 433(4):489-95. PubMed ID: 23528241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological characteristics of 21 Papua New Guinean children with high-grade B-cell lymphoma, which is frequently associated with EBV infection.
    Nomura Y; Lavu EK; Muta K; Niino D; Takeshita M; Hirose S; Nakamura S; Yoshino T; Kikuchi M; Ohshima K
    Pathol Int; 2008 Nov; 58(11):695-700. PubMed ID: 18844934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma.
    Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW
    Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zebularine reactivates silenced E-cadherin but unlike 5-Azacytidine does not induce switching from latent to lytic Epstein-Barr virus infection in Burkitt's lymphoma Akata cells.
    Rao SP; Rechsteiner MP; Berger C; Sigrist JA; Nadal D; Bernasconi M
    Mol Cancer; 2007 Jan; 6():3. PubMed ID: 17214905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential proteomic analysis of endemic and sporadic Epstein-Barr virus-positive and negative Burkitt lymphoma.
    El-Mallawany NK; Day N; Ayello J; Van de Ven C; Conlon K; Fermin D; Basrur V; Elenitoba-Johnson K; Lim M; Cairo MS
    Eur J Cancer; 2015 Jan; 51(1):92-100. PubMed ID: 25466511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity to dexamethasone and absence of bcl-2 protein in Burkitt's lymphoma cell line (Black93) derived from a patient with acute tumor lysis syndrome: comparative study with other BL and non-BL lines.
    Tani A; Tatsumi E; Nakamura F; Kumagai S; Kosaka Y; Sano K; Nakamura H; Amakawa R; Ohno H
    Leukemia; 1996 Oct; 10(10):1592-603. PubMed ID: 8847894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray.
    Bernasconi M; Berger C; Sigrist JA; Bonanomi A; Sobek J; Niggli FK; Nadal D
    Virol J; 2006 Jun; 3():43. PubMed ID: 16756670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.